US equities |
NVDA $241.47 ▲+1.08% SPCX $173.42 ▲+1.36% MU $1,063.50 ▼-0.04% AMD $655.25 ▲+3.72% MRVL $281.94 ▲+3.94% SNDK $1,671.27 ▼-1.93% AVGO $378.52 ▲+4.42% INTC $113.47 ▼-2.35%
FinancialContent

Latest News about Hepatits B

Recent news which mentions Hepatits B

Safety Signals Force Enanta To Stop EDP-721 HBV Program
Tickers ENTA
Tags Phase 1 Trial Small Cap Hepatits B
From Benzinga
Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection
Tickers BEAM
Tags Benzinga Biotech Preclinical Phase
From Benzinga